论文信息 - Myeloid-Derived Suppressor Cells May Predict the Occurrence of Postoperative Complications in Colorectal Cancer Patients—a Pilot Study - 字舞流文

Myeloid-Derived Suppressor Cells May Predict the Occurrence of Postoperative Complications in Colorectal Cancer Patients—a Pilot Study

M. Rubinkiewicz | J. Baran | R. Pach | A. Szczepanik | Izabela Siemińska | J. Zybaczyńska | J. Rogala

[1] K. Węglarczyk,et al. Mo-MDSCs are pivotal players in colorectal cancer and may be associated with tumor recurrence after surgery , 2022, Translational oncology.

[2] D. B. Sacdalan,et al. The Association Between Inflammation and Immunosuppression: Implications for ICI Biomarker Development , 2021, OncoTargets and therapy.

[3] Marie-Pierre L. Gauthier,et al. Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis , 2019, Critical Care.

[4] S. Hua,et al. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk , 2018, Front. Immunol..

[5] D. Gabrilovich,et al. Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.

[6] M. Nishimura,et al. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy , 2008, Cancer Immunology, Immunotherapy.